Literature DB >> 7986687

Cutaneous pseudolymphomas: classification and differential diagnosis.

J U Rijlaarsdam1, R Willemze.   

Abstract

Cutaneous pseudolymphomas are benign hyperplastic lymphoproliferative reactions that simulate cutaneous malignant lymphomas clinically and/or histologically. The differentiation between cutaneous pseudolymphomas and primary cutaneous lymphomas is often very difficult, but is important because it has therapeutic consequences. The term pseudolymphoma does not refer to a specific disease, but to a heterogeneous group of pseudo-B-cell lymphomas and pseudo-T-cell lymphomas. In this article clinical and histological features of this group of disorders will be discussed and the differential diagnostic criteria, that have been used in the past decades to differentiate between cutaneous lymphomas and pseudolymphomas will be critically evaluated.

Entities:  

Mesh:

Year:  1994        PMID: 7986687

Source DB:  PubMed          Journal:  Semin Dermatol        ISSN: 0278-145X


  4 in total

1.  [Cutaneous pseudolymphoma. An example of the relevance of minor surgery in PC].

Authors:  M Solera Suárez; M Beltrán Beltrán; A Bonet Pla
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

2.  Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.

Authors:  V Bakels; J W van Oostveen; S C van der Putte; C J Meijer; R Willemze
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 3.  New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.

Authors:  Kazuyasu Fujii
Journal:  Front Oncol       Date:  2018-06-04       Impact factor: 6.244

4.  CD30+ lymphomatoid skin toxicity secondary to ipilimumab.

Authors:  Amelia E Bush; Andres Garcia; Janet Li; Jonathan Curry; Susan Y Chon
Journal:  JAAD Case Rep       Date:  2020-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.